Navigation Links
Genetic Testing Can Help the US Cut Costs and Improve Health Care
Date:7/25/2011

WASHINGTON, July 25, 2011 /PRNewswire-USNewswire/ -- Genetic testing made possible by the mapping of the human genome can help the US cut costs and create jobs while at the same time improving survival rates for such diseases as cancer, HIV, and heart disease.

This according to Alan Mertz, president of the American Clinical Laboratory Association (ACLA): "Genetic testing is going to be a powerful and increasingly important tool in helping public and private payers get control of over-utilization and inappropriate utilization of health care resources," said Mertz in a recent presentation to the Marwood Group, a health care advisory and financial services company.

"An estimated $30 billion - $110 billion every year could be saved by using genetic tests to select the drug that precisely matches the genetic fingerprint of the patient," said Mertz.

Every year, the US spends about $300 billion on pharmaceuticals, he explained. But studies show that anywhere from 20% to 75% of patients do not respond to drug therapy, often due to drug interactions or incorrect dosing. Roughly half of the time, it is due to a molecular mismatch between the patient and the pharmaceutical, said Mertz.  

"But if we provide patients with more targeted therapy — based upon their own, unique genomic profile — we have clear potential to address some of this inappropriate care," he added.

Mertz cited examples where genetic tests both improve health outcomes and health economics:  In breast cancer, 30% of women have an overabundance of the HER2 protein. Regular chemotherapy will not help them, but a drug called Herceptin does. Genetic testing lets doctors know which patients will respond to the drug, which has been shown to reduce the risk of death by 33% and the risk of recurrence by 52%. The resulting cost savings is $24,000 per patient.

Similarly, genetic tests help physicians select the right drug for patients with metastatic colon cancer, thus avoiding ineffective treatment and reducing adverse events. "According to one estimate, the US health care system could save $700 million annually if test were done before prescribing the drug," said Mertz.

Using genetic tests to select the right dose of the most common blood thinner, warfarin, could save a whopping $1.1 billion annually, according to a 2006 Brookings/AEI estimate, Mertz said. A study from June 2010 in the Journal of the American College of Cardiology reported that use of the test could reduce hospitalizations from inaccurate dosing by 31%.

Mertz also cited a recently released Battelle report that found that between 1988 and 2010, human genome sequencing projects -- which includes genetic testing -- generated $796 billion in US economic output, $244 billion in personal income for Americans, and 3.8 million job-years of employment.

"Genetic testing offers new tools to help us manage disease and use our health care resources wisely," said Mertz. "It also opens a world of economic potential in jobs, growth, and output."

The American Clinical Laboratory Association represents the nation's clinical reference laboratories. For more information go to: www.clinical-labs.org/


'/>"/>
SOURCE American Clinical Laboratory Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Genetics Determine Optimal Drug Dose of Common Anticoagulant
4. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
6. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
7. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
11. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
Breaking Medicine News(10 mins):